Background Shared decision-making is useful to facilitate cancer treatment decisions.
However, it is difficult to make treatment decisions when physician and patient preferences …

Objective To measure preferences of women with ovarian cancer regarding risks, side
effects, costs and benefits afforded by maintenance therapy (MT) with a poly ADP ribose …

Background Treatments aiming at slowing down the progression of Alzheimer's disease
(AD) may soon become available. However, information about the risks that people are …

Background To estimate the perceived value of additional testing with amyloid-PET in Euros
in healthy participants acting as analogue patients with mild cognitive impairment (MCI) …

Background When selecting samples for patient preference studies, it may be difficult or
impractical to recruit participants who are eligible for a particular treatment decision …

Introduction The current therapeutic landscape of Alzheimer's disease (AD) is evolving
rapidly. Our treatment options include new anti-amyloid-β protein disease-modifying …

Introduction In the context of the development of pharmaceutical interventions, expectations
and experiences of participants are essential. Their insights may be particularly helpful to …

Background Better understanding of the factors that influence patients to make a financial
claim for compensation is required to inform policy decisions. This study aimed to assess the …

Introduction The patient's voice in shared decision-making has progressed from physician's
office to regulatory decision-making for medical devices with FDA's Patient Preference …

Objective We aimed to assess the feasibility of developing a discrete-choice experiment
survey to elicit preferences for a treatment to delay cognitive decline among people with a …